Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123511492 | 12351149 | 2 | F | 20160316 | 20160912 | 20160510 | 20160914 | EXP | US-BAYER-2016-058671 | BAYER | 54.00 | YR | A | F | Y | 0.00000 | 20160914 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123511492 | 12351149 | 1 | PS | ADEMPAS | RIOCIGUAT | 1 | UNK | 204819 | |||||||||||
| 123511492 | 12351149 | 2 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | UNK | 204819 | ||||||||||
| 123511492 | 12351149 | 3 | SS | ADEMPAS | RIOCIGUAT | 1 | UNK | 204819 | |||||||||||
| 123511492 | 12351149 | 4 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 1.5 MG, TID | 204819 | 1.5 | MG | TID | |||||||
| 123511492 | 12351149 | 5 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 2 MG, TID | 204819 | 2 | MG | TID | |||||||
| 123511492 | 12351149 | 6 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 2.5 MG, TID | 204819 | 2.5 | MG | TID | |||||||
| 123511492 | 12351149 | 7 | SS | REMODULIN | TREPROSTINIL | 1 | UNK | 0 | |||||||||||
| 123511492 | 12351149 | 8 | SS | ORENITRAM | TREPROSTINIL | 1 | 2.625MG, OM AND 2.5MG IN AFTERNOON AND EVENING | 0 | |||||||||||
| 123511492 | 12351149 | 9 | SS | ORENITRAM | TREPROSTINIL | 1 | 2.5 MG, TID | 0 | 2.5 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123511492 | 12351149 | 1 | Pulmonary arterial hypertension |
| 123511492 | 12351149 | 2 | Pulmonary arterial hypertension |
| 123511492 | 12351149 | 3 | Pulmonary arterial hypertension |
| 123511492 | 12351149 | 4 | Pulmonary arterial hypertension |
| 123511492 | 12351149 | 5 | Pulmonary arterial hypertension |
| 123511492 | 12351149 | 6 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123511492 | 12351149 | HO |
| 123511492 | 12351149 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123511492 | 12351149 | Headache | |
| 123511492 | 12351149 | Investigation abnormal | |
| 123511492 | 12351149 | Nausea | |
| 123511492 | 12351149 | Pain in jaw | |
| 123511492 | 12351149 | Pulmonary endarterectomy | |
| 123511492 | 12351149 | Pulmonary veno-occlusive disease | |
| 123511492 | 12351149 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123511492 | 12351149 | 1 | 20160220 | 0 | ||
| 123511492 | 12351149 | 2 | 20160222 | 0 | ||
| 123511492 | 12351149 | 3 | 20160401 | 0 |